期刊
VASCULAR PHARMACOLOGY
卷 114, 期 -, 页码 139-144出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2018.01.007
关键词
Diabetic vascular complications; lncRNAs; Endothelial; Macrophage; Vascular smooth muscle cells
资金
- National Institutes of Health [R01 DK 065073, R01 HL106089, R01 DK081705, K01 DK104993]
Diabetes leads to markedly accelerated rates of many associated macrovascular complications like hypertension and atherosclerosis, and microvascular complications like nephropathy and retinopathy. High glucose, the hallmark of diabetes, drives changes in vascular and inflammatory cells that promote the development of these complications. Understanding the molecular processes involved in the development of diabetes and its debilitating complications can lead to much needed newer clinical therapies. Recently, long-noncoding RNAs (lncRNAs) have been shown to be important in the biology of vascular cells and there is growing evidence that lncRNAs are also involved in the cell biology relevant to diabetic vascular complications. In this review, we provide an overview of lncRNAs that function in vascular cells, and those that have been linked to diabetic complications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据